Company intelligence / Profile preview

Cenexi

Osny, Ile de France, Francecenexi.com ↗

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Cenexi is an established European CDMO specializing in sterile and injectable pharmaceutical products. The company provides formulation development through to commercial-scale manufacturing for both innovative biotechs and large pharma companies. It has strong expertise in high-potency compounds including cytotoxics, hormones, monoclonal antibodies, antibody-drug conjugates and peptides. Most of its business is focused on sterile injectables (70%+ of turnover), with capabilities spanning clinical trial material production to full commercial supply.

Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugatePeptidesBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Cenexi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cenexi.

Explore the full profile